Crescita Therapeutics Company Top Insiders

CRRTF Stock  USD 0.45  0.00  0.00%   
Crescita Therapeutics employs about 2 people. The company is managed by 2 executives with a total tenure of roughly 5 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Examination of Crescita Therapeutics' management performance can provide insight into the company performance.
Dominic KingSmith  Insider
VP Devel
Francois Lafortune  Insider
Ex GM
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Crescita Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Crescita Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of 0.0227 % which means that it generated a profit of $0.0227 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0318 %, meaning that it generated $0.0318 on every $100 dollars invested by stockholders. Crescita Therapeutics' management efficiency ratios could be used to measure how well Crescita Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.

Crescita Therapeutics Workforce Comparison

Crescita Therapeutics is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 312. Crescita Therapeutics maintains roughly 2.0 in number of employees contributing less than 1% to equities under Health Care industry.
The company has Profit Margin (PM) of 0.03 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.04 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.04.

Crescita Therapeutics Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Crescita Therapeutics Price Series Summation is a cross summation of Crescita Therapeutics price series and its benchmark/peer.

Crescita Therapeutics Notable Stakeholders

A Crescita Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Crescita Therapeutics often face trade-offs trying to please all of them. Crescita Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Crescita Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About Crescita Therapeutics Management Performance

The success or failure of an entity such as Crescita Therapeutics often depends on how effective the management is. Crescita Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Crescita management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Crescita management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. Crescita Therapeutics Inc. was incorporated in 2016 and is headquartered in Laval, Canada. Crescita Therapeutics is traded on OTC Exchange in the United States.

Crescita Therapeutics Workforce Analysis

Traditionally, organizations such as Crescita Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Crescita Therapeutics within its industry.

Crescita Therapeutics Manpower Efficiency

Return on Crescita Therapeutics Manpower

Revenue Per Employee8.4M
Revenue Per Executive8.4M
Net Loss Per Employee552.5K
Net Loss Per Executive552.5K

Complementary Tools for Crescita Pink Sheet analysis

When running Crescita Therapeutics' price analysis, check to measure Crescita Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crescita Therapeutics is operating at the current time. Most of Crescita Therapeutics' value examination focuses on studying past and present price action to predict the probability of Crescita Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crescita Therapeutics' price. Additionally, you may evaluate how the addition of Crescita Therapeutics to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Valuation
Check real value of public entities based on technical and fundamental data
Technical Analysis
Check basic technical indicators and analysis based on most latest market data